Anaferon children drops for oral use from 1month, 25ml

Product description

Anaferon for children in the form of drops is an original antiviral drug specially developed for the treatment of acute respiratory infections of the upper respiratory tract in children from 1 month to 3 years inclusive. It has a wide range of antiviral activity, including influenza. It has a favorable security profile. If necessary, it can be combined with other antiviral, antibacterial and symptomatic agents.

Composition

Composition per 1 ml of oral drops: Active ingredients: Affinity-purified human gamma interferon antibodies – 0.006 g*. * administered as a mixture of three active aqueous dilutions of the substance, diluted respectively in 10012,10030,10050 times. Auxiliary substances: maltitol-0.06 g, glycerol-0.03 g, potassium sorbate-0.00165 g, citric acid anhydrous-0.0002 g, purified water-up to 1 ml

Pharmacological action

In the course of preclinical and clinical studies, the effectiveness of the drug against influenza viruses, herpes simplex viruses of types 1 and 2 (labial herpes, genital herpes), other herpes viruses (chickenpox, infectious mononucleosis), rotavirus has been proven. The drug reduces the concentration of the virus in the affected tissues, affects the system of endogenous interferons and their associated cytokines, induces the formation of endogenous “early” interferons (IFN a / β) and interferon gamma (IFN γ). It stimulates humoral and cellular immune responses. Increases the production of antibodies (including secretory IgA), activates the functions of T-effectors, T-helpers( Tx), and normalizes their ratio. Increases the functional reserve of Tx and other cells involved in the immune response. It is an inducer of a mixed Txl and Tx2 immune response: it increases the production of Txl (IFN y, IL-2) and Tx2 (IL-4,10) cytokines, restores (modulates) the Tx1/Tx2 balance. Increases the functional activity of phagocytes and natural killer cells (EC cells).

Indications

Treatment of acute respiratory infections of the upper respiratory tract in children aged 1 month to 3 years inclusive.

Use during pregnancy and lactation

The safety of using Anaferon for children in pregnant women and during lactation has not been studied.

Contraindications

Increased individual sensitivity to the components of the drug, children under 1 month of age. Hereditary fructose intolerance (due to the presence of maltitol in the composition).

Side effects

When used according to the indicated indications and in the indicated dosages, no side effects were detected. Possible reactions of increased individual sensitivity to the components of the drug.

Interaction

No cases of incompatibility with other medicinal products have been reported so far.

How to take, course of use and dosage

10 drops per reception (drops are dosed in a spoon). On the first day of treatment: for the first 2 hours,10 drops every 30 minutes, then, in the remaining time,3 more times at regular intervals. From the 2nd to the 5th day: 10 drops 3 times a day. The drug is taken outside of meals. On the first day of treatment, the first five doses of the drug should be carried out in the interval between feedings or 15 minutes before feeding the baby or taking fluids.

Overdose

No cases of overdose have been identified so far.

Description

Colorless or almost colorless transparent liquid.

Special instructions

The drug contains maltitol, and therefore it is not recommended to prescribe it to patients with congenital fructose intolerance.

Form of production

Drops for oral use.

Storage conditions

At a temperature not exceeding 25 °C.

Keep out of reach of children.

Shelf

life is 3 years. Do not use after the expiration date.

Active ingredient

Antibodies

Dosage form

Drops for oral use

Description

Children older than 1 month, For children

Indications

Herpes, Flu, Flu and Cold Prevention, Common Cold